Stockreport

Tempus Announces the Clinical Launch of its Immune Profile Score Algorithmic Test [Yahoo! Finance]

Tempus AI, Inc. - Class A  (TEM) 
PDF CHICAGO, November 07, 2024 BUSINESS WIRE )--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient car [Read more]